AG真人官方

Form 4 filing summary 鈥� KeyCorp (KEY), 07/01/2025: Director Barbara R. Snyder converted 35,955 deferred shares (transaction code M) into an equal number of common shares. The conversion increased her directly held common-share position to 71,632 shares. No open-market purchase or sale price was reported because the shares derive from KeyCorp鈥檚 Directors鈥� Deferred Share Sub-Plan, where each deferred share is economically equivalent to a common share. Following the transaction, Snyder still holds 177,901 deferred shares that remain subject to the plan. The filing also notes that direct ownership totals include roughly 175 common shares obtained through the June 2025 dividend-reinvestment program, and deferred-share holdings include about 2,765 dividend-equivalent units accrued during the same period. As there was no disposition of shares and the transaction merely settles a long-standing equity award, the impact on KeyCorp鈥檚 public float and insider sentiment is modest.

The Form 4 filing reports that Chemours Company (CC) director Courtney Mather was awarded 2,292 deferred stock units (DSUs) on 30 June 2025. Each DSU equals one share of common stock and will be settled in the first month after the director leaves the board. The award is recorded at a reference price of $11.45 per unit. After the grant, Mather directly owns 2,292 derivative securities; no sales or additional purchases of common stock were disclosed. Apart from this routine director compensation grant, the filing contains no other material transactions or changes in ownership.

On 30 June 2025, Wintrust Financial Corp. (WTFC) director Brian A. Kenney reported the acquisition of 420 common shares under the company鈥檚 Director鈥檚 Deferred Fee and Stock Plan, as disclosed in a Form 4 filing. The shares were credited at a price of $112.46, increasing Kenney鈥檚 direct beneficial ownership to 11,214 WTFC shares. The transaction is coded 鈥淎,鈥� indicating an award rather than an open-market purchase, and no derivative securities were involved. While routine in nature, the filing slightly increases insider ownership and may be viewed as a signal of continued alignment between the director and shareholder interests.

Orchid Island Capital, Inc. (ORC) 鈥� Form 4 insider transaction dated 06/26/2025

Chief Financial Officer and Director G. Hunter Haas IV reported the vesting and settlement of previously granted Performance Units under the company鈥檚 2021鈥�2023 Long-Term Equity Incentive Plans.

• Shares acquired: 3,755 common shares were issued at a conversion price of $0 following the vesting of three separate Performance Unit awards (original grant dates: 03/28/2022, 04/13/2023 and 03/19/2024).
• Shares withheld for taxes: 1,403 shares were automatically surrendered to the issuer at the 06/25/2025 closing price of $7.01 to satisfy statutory withholding.

After the transactions, Haas directly owns 73,702 ORC common shares (an increase of 2,352 shares, or +3.3% versus pre-transaction holdings) and retains 16,882.83 unexercised Performance Units.

The activity reflects routine equity-award vesting rather than open-market buying; nonetheless, the net increase slightly aligns executive incentives with shareholders. No cash proceeds were received by the insider other than the shares withheld for tax settlement. There are no indications of option exercises, open-market sales, or material changes to corporate strategy within this filing.

Orchid Island Capital, Inc. (ORC) 鈥� Form 4 filing dated 26 June 2025

Chief Executive Officer and Director Robert E. Cauley reported routine equity-compensation activity. A total of 4,644 common shares were issued upon vesting of performance units granted in 2022-2024 under the company鈥檚 equity incentive plans (transaction code M). To satisfy related tax-withholding obligations, 993 shares were automatically surrendered to the issuer at the 25 June 2025 closing price of $7.01 (transaction code F). Net of withholding, Cauley鈥檚 direct ownership increased by 3,651 shares to 141,602 shares.

The derivative table shows the exercise of 4,644.26 performance units, leaving 19,881.1 performance units outstanding. No open-market purchases or sales occurred, and cash was only used to settle fractional shares. The filing does not disclose any changes to company fundamentals or strategic plans.